AEGON ASSET MANAGEMENT UK Plc increased its holdings in Endava plc (NYSE:DAVA - Free Report) by 8.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 245,772 shares of the company's stock after purchasing an additional 19,669 shares during the period. AEGON ASSET MANAGEMENT UK Plc owned 0.43% of Endava worth $6,279,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of DAVA. Blue Trust Inc. bought a new position in shares of Endava in the third quarter worth about $30,000. Headlands Technologies LLC purchased a new stake in Endava in the first quarter valued at $49,000. Signaturefd LLC increased its holdings in Endava by 84.1% in the third quarter. Signaturefd LLC now owns 1,939 shares of the company's stock valued at $50,000 after buying an additional 886 shares in the last quarter. Seven Eight Capital LP purchased a new position in Endava during the second quarter worth approximately $216,000. Finally, Precision Wealth Strategies LLC raised its position in Endava by 6.7% during the third quarter. Precision Wealth Strategies LLC now owns 8,571 shares of the company's stock worth $219,000 after acquiring an additional 540 shares during the period. Hedge funds and other institutional investors own 62.23% of the company's stock.
DAVA has been the subject of several research reports. Citigroup dropped their price target on Endava from $30.00 to $27.00 and set a "neutral" rating for the company in a research report on Monday, October 28th. JPMorgan Chase & Co. lifted their target price on shares of Endava from $41.00 to $47.00 and gave the company an "overweight" rating in a report on Friday, September 6th. Guggenheim cut their target price on shares of Endava from $45.00 to $40.00 and set a "buy" rating on the stock in a research note on Wednesday. Needham & Company LLC decreased their price objective on Endava from $42.00 to $33.00 and set a "buy" rating for the company in a research note on Friday, September 20th. Finally, Susquehanna dropped their target price on Endava from $66.00 to $55.00 and set a "positive" rating on the stock in a report on Friday, September 20th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Endava has a consensus rating of "Moderate Buy" and a consensus target price of $41.21.
Read Our Latest Research Report on DAVA
Shares of NYSE DAVA opened at $26.37 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.23. The firm has a 50-day moving average price of $26.87 and a 200 day moving average price of $28.55. Endava plc has a 52 week low of $23.28 and a 52 week high of $81.06. The stock has a market capitalization of $1.52 billion, a price-to-earnings ratio of 73.25 and a beta of 1.21.
Endava (NYSE:DAVA - Get Free Report) last announced its quarterly earnings results on Thursday, September 19th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.13). Endava had a return on equity of 2.75% and a net margin of 2.30%. The firm had revenue of $245.30 million for the quarter, compared to analysts' expectations of $248.65 million. Equities research analysts anticipate that Endava plc will post 0.77 EPS for the current fiscal year.
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.